# Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold

> **NCT02735070** · PHASE3 · UNKNOWN · sponsor: **Brainfarma Industria Química e Farmacêutica S/A** · enrollment: 366 (estimated)

## Conditions studied

- Cold

## Interventions

- **DRUG:** Resfenol
- **DRUG:** Coristina d

## Key facts

- **NCT ID:** NCT02735070
- **Lead sponsor:** Brainfarma Industria Química e Farmacêutica S/A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 366 (ESTIMATED)
- **Last updated:** 2016-04-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02735070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02735070, "Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02735070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*